ストックスクリーナーアプリを入手
18.79
0.21%
-0.04
アフターアワーズ：
18.70
-0.09
-0.48%
前日終値:
$18.83
開ける：
$18.34
24時間の取引高:
1.90M
Relative Volume:
0.73
時価総額：
$2.67B
収益：
-
当期純損益:
$-412.89M
株価収益率:
-4.8679
EPS:
-3.86
ネットキャッシュフロー:
$-361.93M
1週間 パフォーマンス:
+2.34%
1か月 パフォーマンス:
+21.62%
6か月 パフォーマンス:
+60.60%
1年 パフォーマンス:
-38.01%
1日の値動き範囲:
$18.34
$19.41
1週間の範囲:
$18.11
$20.07
52週間の値動き範囲:
$6.36
$31.32
Dyne Therapeutics Inc Stock (DYN) Company Profile
DYN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DYN
Dyne Therapeutics Inc
|
18.79 | 2.69B | 0 | -412.89M | -361.93M | -3.86 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Dyne Therapeutics Inc Stock (DYN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-10 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-08-25 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2025-06-24 | 開始されました | Bernstein | Mkt Perform |
| 2025-06-11 | 再開されました | Raymond James | Outperform |
| 2025-06-02 | 再開されました | Oppenheimer | Outperform |
| 2025-05-29 | 開始されました | Evercore ISI | Outperform |
| 2025-03-12 | 開始されました | BMO Capital Markets | Outperform |
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2024-12-13 | 開始されました | Robert W. Baird | Outperform |
| 2024-11-26 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-10-24 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-05-21 | 繰り返されました | Chardan Capital Markets | Buy |
| 2024-04-30 | 開始されました | Morgan Stanley | Overweight |
| 2024-02-20 | 開始されました | H.C. Wainwright | Buy |
| 2023-02-27 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-02-15 | 開始されました | Oppenheimer | Outperform |
| 2023-01-26 | 開始されました | Guggenheim | Buy |
| 2022-07-20 | 開始されました | Chardan Capital Markets | Buy |
| 2022-07-12 | 開始されました | Raymond James | Outperform |
| 2020-10-12 | 開始されました | JP Morgan | Overweight |
| 2020-10-12 | 開始されました | Jefferies | Buy |
| 2020-10-12 | 開始されました | Piper Sandler | Overweight |
| 2020-10-12 | 開始されました | Stifel | Buy |
すべてを表示
Dyne Therapeutics Inc (DYN) 最新ニュース
Will Dyne Therapeutics Inc. stock deliver better than expected guidanceJuly 2025 Gainers & Free Growth Oriented Trading Recommendations - newser.com
Dyne Therapeutics Inc Stock Analysis and ForecastHigh Dividend Yield Stocks & Outstanding Portfolio Tips - earlytimes.in
Is Dyne Therapeutics Inc. stock attractive for long term wealth building2025 Market Sentiment & Short-Term High Return Ideas - newser.com
Dyne Therapeutics Inc. stock volume spike explainedPortfolio Return Report & Stock Portfolio Risk Management - newser.com
Is Dyne Therapeutics Inc. reversing from oversold territoryPortfolio Risk Summary & Accurate Buy Signal Alerts - newser.com
JP Morgan Maintains Dyne Therapeutics (DYN) Neutral Recommendation - Nasdaq
Will Dyne Therapeutics Inc. stock go up soonJuly 2025 Movers & High Yield Equity Trading Tips - newser.com
Why Dyne Therapeutics Inc. stock is seen as undervaluedTrade Volume Report & Real-Time Buy Zone Alerts - newser.com
Dyne Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Market Mood & Real-Time Stock Movement Alerts - newser.com
JP Morgan Lowers Price Target for Dyne Therapeutics (DYN) | DYN Stock News - GuruFocus
What drives Dyne Therapeutics Inc stock priceLong-Term Investment Plans & Free Tap Rapid Wealth - earlytimes.in
Technical analysis overview for Dyne Therapeutics Inc. stock2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
How moving averages guide Dyne Therapeutics Inc. tradingJuly 2025 Final Week & Free Community Consensus Stock Picks - newser.com
Can you recover from losses in Dyne Therapeutics Inc.2025 AllTime Highs & Safe Capital Growth Tips - newser.com
Oppenheimer Maintains Dyne Therapeutics (DYN) Perform Recommendation - Nasdaq
Is Dyne Therapeutics Inc. stock entering bullish territoryTrade Signal Summary & Growth Oriented Trading Recommendations - newser.com
Dyne Therapeutics (DYN) Sees Price Target Cut by Oppenheimer | D - GuruFocus
Oppenheimer Adjusts Price Target on Dyne Therapeutics to $11 From $13, Maintains Perform Rating - MarketScreener
Analyzing Dyne Therapeutics Inc. with risk reward ratio chartsMarket Sentiment Report & Real-Time Volume Analysis - newser.com
Historical volatility pattern of Dyne Therapeutics Inc. visualizedJuly 2025 PostEarnings & Daily Price Action Insights - newser.com
Is Dyne Therapeutics Inc. stock gaining market shareDay Trade & Stepwise Swing Trade Plans - newser.com
Analysts Offer Insights on Healthcare Companies: Cencora (COR), Dyne Therapeutics (DYN) and Enhabit, Inc (EHAB) - The Globe and Mail
Can trapped investors hope for a rebound in Dyne Therapeutics Inc.Market Rally & Smart Investment Allocation Tips - newser.com
HC Wainwright & Co. Raises Price Target for Dyne Therapeutics (D - GuruFocus
Dyne Therapeutics Narrowed Losses And Eyes Major Drug Launches - Finimize
Decoding Dyne Therapeutics Inc (DYN): A Strategic SWOT Insight - GuruFocus
Dyne Therapeutics Advances in Neuromuscular Disease Therapies - TipRanks
Dyne Therapeutics Inc (DYN) 財務データ
収益
当期純利益
現金流量
EPS
1.43%
0.07%
大文字化:
|
ボリューム (24 時間):